Xinyue Zhang

3PUBLICATIONS
10CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 04, 2023
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features.

Wei Cui, Xin-Yue Zhang, Zheng Li

|Apr 24, 2023
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

Sining Liu, Xinyue Zhang, Haiping Dai

|Nov 08, 2021
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation.

Xin-Yue Zhang, Hai-Ping Dai, Ling Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Hai-Ping Dai

2 joint publications

Jia Yin

2 joint publications

Sining Liu

1 joint publications

Zheng Li